Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Craig A. Wheeler: trading record in brief
Filings by Craig A. Wheeler span 3 companies, the busiest being Amicus Therapeutics, Inc., Apellis Pharmaceuticals, Inc. and Momenta Pharmaceuticals Inc. Between 9 February 2016 and 14 May 2026, the trades on record add up to 10 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 14 May 2026, reports a transaction in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Craig A. Wheeler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
24,444 sharesCommon StockSEC:0001193125-26-224585:0
84,631 shares@ US$14.500.026% mcap100.0% of flowCommon StockSEC:0001193125-26-182285:0
7,961 shares0Common StockSEC:0001492422-26-000008:0
20,414 shares0Common StockSEC:0000950170-25-083196:0
16,483 shares0Common StockSEC:0001127602-25-012384:0
11,847 shares0Common StockSEC:0000950170-24-071009:0
8,584 shares0Common StockSEC:0001209191-23-036412:0
12,671 shares0Common StockSEC:0001209191-22-035857:0
10,115 shares0Common StockSEC:0001209191-21-040379:0
63,000 sharesCommon StockSEC:0001179110-16-018968:0
10 of 10 declarations
